Signalway

Anti-MEK-2 (pThr394) Antibody

#11008 (also 11008-1) · western blot

110
Citing papers
4k
Combined citations
Supplier page Find this product

Research areas

Melanoma and MAPK Pathways9Epigenetics and DNA Methylation7Cytokine Signaling Pathways and Interactions7PI3K/AKT/mTOR signaling in cancer7Cancer Mechanisms and Therapy7Alzheimer's disease research and treatments6Cancer, Hypoxia, and Metabolism6Cancer Cells and Metastasis6

Papers citing this product

1
Stabilization of phosphofructokinase 1 platelet isoform by AKT promotes tumorigenesis
Nature Communications·2017·342 cit.·DOI
2
Brain-derived neurotrophic factor protects against tau-related neurodegeneration of Alzheimer’s disease
Translational Psychiatry·2016·261 cit.·DOI
3
Berberine in combination with cisplatin induces necroptosis and apoptosis in ovarian cancer cells
Biological Research·2019·208 cit.·DOI
4
Glut1 promotes cell proliferation, migration and invasion by regulating epidermal growth factor receptor and integrin signaling in triple-negative breast cancer cells
BMB Reports·2017·146 cit.·DOI
5
miR-665 expression predicts poor survival and promotes tumor metastasis by targeting NR4A3 in breast cancer
Cell Death and Disease·2019·127 cit.·DOI
6
ER-α36, a Variant of ER-α, Promotes Tamoxifen Agonist Action in Endometrial Cancer Cells via the MAPK/ERK and PI3K/Akt Pathways
PLoS ONE·2010·122 cit.·DOI
7
Baicalin induces cellular senescence in human colon cancer cells via upregulation of DEPP and the activation of Ras/Raf/MEK/ERK signaling
Cell Death and Disease·2018·118 cit.·DOI
8
Drp1-mediated mitochondrial fission contributes to baicalein-induced apoptosis and autophagy in lung cancer via activation of AMPK signaling pathway
International Journal of Biological Sciences·2020·115 cit.·DOI
9
Olfactory bulb neuroproteomics reveals a chronological perturbation of survival routes and a disruption of prohibitin complex during Alzheimer’s disease progression
Scientific Reports·2017·109 cit.·DOI
10
The effects of cannabidiol and its synergism with bortezomib in multiple myeloma cell lines. A role for transient receptor potential vanilloid type‐2
International Journal of Cancer·2013·100 cit.·DOI

Also available from other vendors

This target has 1.1k citing papers across all vendors combined

VendorProductPricePapers
Bio-RadRabbit Anti-Rat MEK 5 Polyclonal antibody, Unconjugated—200
MedChemExpressMEK-1/2 Antibody (YA6149)—200
ImmunoWayMEK1/2 (PT0433R) PT™ Rabbit mAb—146
ImmunoWayMEK-1/2 (phospho Ser218/222) Polyclonal Antibody—1
RayBiotechMEK 1 (pThr386)—200
NovusRabbit Anti-Rat MEK 5, phospho (Ser311 / Thr315) Polyclonal, Unconjugated—200
SignalwayRabbit Anti-MEK-2, phospho (Thr394) Polyclonal Antibody, Unconjugated—28
SignalwayAnti-MEK-2 Antibody—110
SignalwayRabbit Anti-MEK-2 Polyclonal Antibody, Unconjugated—14
Anti-MEK-2 (pThr394) Antibody — Evidence — PubIndex